Non-adherence to the therapy in Crohn's disease patients: prevalence and risk factors

Arquivos De Gastroenterologia
Rita de Cássia Azevedo Couto CornélioJúlio Maria Fonseca Chebli

Abstract

Non-adherence to therapy, in any degree is a common event and occurs in several circumstances. It is one of most common cause of fail in therapy of chronic diseases and Crohn's disease is not an exception. To evaluate in patients with Crohn's disease the prevalence and the risk factors to non-adherence to therapy. From July 2006, for 12 months, were included prospectively, for non-adhesion to therapy 100 patients with Crohn's disease that were assisted in a Center for Inflammatory Bowel Diseases of University Hospital of Federal University of Juiz de Fora, MG, in Brazil. A modified Morisky & Green Test for Measure of Adherence to Therapy was answered by all of them. According to test the patients were classified in two groups defined as adherence and non-adherence, respectively, and the last one was separated in intentional and non-intentional adhesion. Clinical, psychological and pharmacotherapeutics variables were sought to find the factors related to non-adherence. Sixty four percent of total group were noticed to have a score of non-adherence to therapy according to used test and non-intentional was the most common type of behavior in such patients, and they demonstrated to be conscious of therapy. The comparison of adheren...Continue Reading

References

Nov 1, 1990·Gut·I W FellowsG K Holmes
Jan 1, 1989·Scandinavian Journal of Gastroenterology. Supplement·J E Lennard-Jones
Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Apr 1, 1997·Journal of Clinical Epidemiology·J R Ickovics, A W Meisler
Jan 12, 2001·Journal of Clinical Gastroenterology·G NigroC Sategna-Guidetti
Nov 6, 2001·The American Journal of Gastroenterology·S V KaneS B Hanauer
Jan 26, 2002·Lancet·Fergus Shanahan
Jan 25, 2003·The American Journal of Medicine·Sunanda KaneStephen Hanauer
Jul 19, 2003·Alimentary Pharmacology & Therapeutics·M J Shale, S A Riley
Jul 23, 2003·The American Journal of Gastroenterology·Maida J SewitchPatricia L Dobkin
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH
Jul 6, 2004·The American Journal of Gastroenterology·Asher KornbluthUNKNOWN Practice Parameters Committee of the American College of Gastroenterology
Sep 24, 2004·Archives of Disease in Childhood·P-A MichaudR Viner
Jun 29, 2005·Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva·A López San RománD Boixeda
Oct 22, 2005·Inflammatory Bowel Diseases·Laura M Mackner, Wallace V Crandall
Feb 17, 2006·Alimentary Pharmacology & Therapeutics·S V Kane
Apr 18, 2007·The American Journal of Gastroenterology·Jason P EdigerCharles N Bernstein
Oct 24, 2007·Alimentary Pharmacology & Therapeutics·R D'IncàG C Sturniolo
Mar 5, 2008·Arquivos De Gastroenterologia·Nathalie de Lourdes Souza DewulfLuiz Ernesto de Almeida Troncon

❮ Previous
Next ❯

Citations

Oct 9, 2020·BioMed Research International·Laíla D AndradeGenoile O Santana

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology
Brooke BentleyAnn R Peden
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
Mike Crilly, Aneez Esmail
© 2022 Meta ULC. All rights reserved